Filing Details

Accession Number:
0001209191-16-101528
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-02-23 17:45:34
Reporting Period:
2016-02-19
Filing Date:
2016-02-23
Accepted Time:
2016-02-23 17:45:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
353569 Quidel Corp QDEL In Vitro & In Vivo Diagnostic Substances (2835) 942573850
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1406652 C Douglas Bryant 12544 High Bluff Drive, Suite 200
San Diego CA 92130
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-02-19 3,700 $13.91 254,293 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The weighted average purchase price for these transactions was $13.91 per share, with a range of $13.87 to $13.98 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares purchased at each separate price.
  2. The amount of securities beneficially owned following this transaction include an additional 1,189 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan.